India, June 8 -- Biotech startup Immuneel Therapeutics announced a Rs.100 Cr Series B fundraise from Singularity AMC, Rainmatter by Zerodha, along with participation from existing backers including founder Kiran Mazumdar-Shaw, Eight Roads Ventures, F-Prime Capital, and a host of undisclosed HNIs.

The Bengaluru-based company plans to deploy the freshly raised funds towards scaling Immuneel's GMP manufacturing capacity, advancing its next-gen deep tech cell and gene therapy pipeline and pushing geographical footprint across Asia Pacific and Middle East.

Founded in 2018 by Mazumdar-Shaw, Kush M Parmar and Siddhartha Mukherjee, Immuneel Therapeutics offers cell and gene therapies such as chimeric antigen receptor T (CAR-T) cell therapy in I...